The FDA has authorized new bivalent COVID-19 booster shots from Pfizer and Moderna for emergency use for all Americans 12 and over, according to a Sept. 1 report from the Baltimore-based Johns Hopkins Bloomberg School of Public Health.
7 things for ASCs to know about the newest COVID-19 booster
